International Alliance for Cancer Early Detection (ACED)

The University of Cambridge is part of the International Alliance for Cancer Early Detection (ACED), a new £55 million partnership between Cancer Research UK, the Canary Center at Stanford University, the University of Cambridge, the Knight Cancer Institute at OHSU, University College London and the University of Manchester.

The purpose of ACED is to unite world-leading researchers to tackle the biggest challenges in the early detection of cancer, an important area of unmet clinical need. Please see the pages below for further information.

  • Funding calls for collaborative projects and travel between ACED member centres will be announced regularly and detailed on our funding page
  • Current ACED projects involving Cambridge will be listed on our research projects page
  • See our events page for ACED networking events and other opportunities

PIs at Cambridge University can become a member of the ACED Cambridge Centre and receive updates on funding and other opportunities by contacting ACED Cambridge Programme Manager Wendy Alderton.

About the International Alliance for Cancer Early Detection (ACED)

More information about the Alliance and the Cambridge ACED member centre.

ACED Clinic Cambridge

Providing world-leading resources and facilities to enable ACED members across the Alliance to conduct first-in-human clinical trials of new approaches to early cancer detection.

Regulatory advice for Alliance members

Guidance for ACED members across the Alliance on navigating the regulatory environment, so that new approaches to early cancer detection can be translated for patient benefit.